China authorizes Livzon Pharma’s COVID-19 vaccine for emergency use
New protein-based vaccine to be used as booster jab, local media reports.
Abone Ol
China has approved Livzon Pharmaceutical Group's COVID-19 vaccine for emergency use, local media reported on Saturday.
Livzon’s protein-based vaccine is the eighth domestically developed vaccine that will be used as a booster shot in the country where nearly 90% of the population have received their primary vaccinations, according to Caixin Global’s website.
Most Read News
-
California wildfire burns over 1,300 acres, thousands
-
Washington demands ‘major role’ in Greenland: Report
-
Russia, Ukraine report civilian casualties following
-
Suspected Ukrainian drone shot down by NATO jet over
-
Under Israeli fire, southern Lebanon hospital races to s
-
Global Sumud Flotilla says Israeli army vessels
-
Italy prison overcrowding reaches 139%, suicides and
-
Israeli finance minister says ICC arrest warrant issued
